argenx Stock Forecast, Price & News

argenx (NASDAQ:ARGX) Frequently Asked Questions

Is argenx a buy right now?

17 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for argenx in the last year. There are currently 5 hold ratings, 11 buy ratings and 1 strong buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" argenx stock.
View analyst ratings for argenx or view top-rated stocks.

How has argenx's stock price been impacted by Coronavirus (COVID-19)?

argenx's stock was trading at $133.81 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, ARGX stock has increased by 106.3% and is now trading at $276.10.
View which stocks have been most impacted by COVID-19.

Are investors shorting argenx?

argenx saw a increase in short interest in the month of November. As of November 15th, there was short interest totaling 1,000,000 shares, an increase of 32.7% from the October 31st total of 753,400 shares. Based on an average daily volume of 179,300 shares, the short-interest ratio is presently 5.6 days. Currently, 2.0% of the shares of the stock are sold short.
View argenx's Short Interest.

When is argenx's next earnings date?

argenx is scheduled to release its next quarterly earnings announcement on Thursday, March 3rd 2022.
View our earnings forecast for argenx.

How were argenx's earnings last quarter?

argenx SE (NASDAQ:ARGX) released its quarterly earnings data on Wednesday, October, 27th. The company reported ($4.10) EPS for the quarter, topping the Zacks' consensus estimate of ($4.48) by $0.38. argenx had a negative trailing twelve-month return on equity of 24.48% and a negative net margin of 73.28%. During the same quarter last year, the firm posted ($3.96) earnings per share.
View argenx's earnings history.

What price target have analysts set for ARGX?

17 analysts have issued 12-month price objectives for argenx's stock. Their forecasts range from $250.00 to $430.00. On average, they anticipate argenx's stock price to reach $352.80 in the next year. This suggests a possible upside of 27.8% from the stock's current price.
View analysts' price targets for argenx or view top-rated stocks among Wall Street analysts.

Who are argenx's key executives?

argenx's management team includes the following people:

• Tim van Hauwermeiren, Chief Executive Officer & Executive Director
• R. Keith Woods, Chief Operating Officer
• Karl Gubitz, Chief Financial Officer
• Hans J. W. de Haard, Chief Scientific Officer
• Wim Parys, Chief Medical Officer

Who are some of argenx's key competitors?

Some companies that are related to argenx include Biogen (BIIB), Seagen (SGEN), Bio-Techne (TECH), Novozymes A/S (NVZMY), Novavax (NVAX), Repligen (RGEN), QIAGEN (QGEN), Acceleron Pharma (XLRN), Neurocrine Biosciences (NBIX), CRISPR Therapeutics (CRSP), Denali Therapeutics (DNLI), Exelixis (EXEL), Beam Therapeutics (BEAM), Abcam (ABCM) and Fate Therapeutics (FATE).
View all of ARGX's competitors.

What other stocks do shareholders of argenx own?

Based on aggregate information from My MarketBeat watchlists, some companies that other argenx investors own include Galapagos (GLPG), Kohl's (KSS), AcelRx Pharmaceuticals (ACRX), Gilead Sciences (GILD), Neurocrine Biosciences (NBIX), Pfizer (PFE), CRISPR Therapeutics (CRSP), Fate Therapeutics (FATE), NVIDIA (NVDA) and Sarepta Therapeutics (SRPT).

When did argenx IPO?

(ARGX) raised $65 million in an initial public offering (IPO) on Thursday, May 18th 2017. The company issued 3,600,000 shares at $18.18 per share. Cowen and Company and Piper Jaffray served as the underwriters for the IPO and JMP Securities and Wedbush PacGrow were co-managers.

What is argenx's stock symbol?

argenx trades on the NASDAQ under the ticker symbol "ARGX."

Who are argenx's major shareholders?

argenx's stock is owned by many different retail and institutional investors. Top institutional shareholders include Artisan Partners Limited Partnership (5.57%), Bellevue Group AG (1.91%), Jennison Associates LLC (1.62%), BlackRock Inc. (1.48%), Wellington Management Group LLP (1.30%) and Capital World Investors (1.28%).

Which major investors are selling argenx stock?

ARGX stock was sold by a variety of institutional investors in the last quarter, including BVF Inc. IL, American Century Companies Inc., Artisan Partners Limited Partnership, Caption Management LLC, ArrowMark Colorado Holdings LLC, Thrivent Financial for Lutherans, TimesSquare Capital Management LLC, and Eaton Vance Management.

Which major investors are buying argenx stock?

ARGX stock was bought by a variety of institutional investors in the last quarter, including Point72 Asset Management L.P., BlackRock Inc., Wellington Management Group LLP, RTW Investments LP, Jennison Associates LLC, Artal Group S.A., Caas Capital Management LP, and Janus Henderson Group PLC.

How do I buy shares of argenx?

Shares of ARGX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is argenx's stock price today?

One share of ARGX stock can currently be purchased for approximately $276.10.

How much money does argenx make?

argenx has a market capitalization of $14.22 billion and generates $41.60 million in revenue each year. The company earns $-604.19 million in net income (profit) each year or ($7.43) on an earnings per share basis.

How many employees does argenx have?

argenx employs 336 workers across the globe.

What is argenx's official website?

The official website for argenx is www.argenx.com.

Where are argenx's headquarters?

argenx is headquartered at Willemstraat 5, Breda P7, 4811 AH.

How can I contact argenx?

argenx's mailing address is Willemstraat 5, Breda P7, 4811 AH. The company can be reached via phone at (176) 303-0488 or via email at [email protected].